Professor of Internal Medicine
Program Director of Fellowship
Transplant Hepatology
[email protected]
Available to mentor
Robert John Fontana, MD
Professor
-
Fellow, GastroenterologyUniversity of Michigan, Ann Arbor, Michigan, 1995
-
Chief Medical ResidentSt. Joseph Hospital, Chicago, Illinois, 1992
-
Residency, Internal MedicineNorthwestern University, Chicago, Illinois, 1991
-
B.S. ChemistryWayne State University, Detroit, Michigan, 1984
-
Likhitsup A, Fontana RJ. Curr Opin Gastroenterol, 2024 May 1; 40 (3): 164 - 171.Journal ArticleDiagnosis and management of immune mediated liver injury from checkpoint inhibitors.
DOI:10.1097/MOG.0000000000001015 PMID: 38375823 -
Shenoy A, Fontana RJ. Hepatology, 2024 May 1; 79 (5): 979 - 982.Journal ArticleHDV screening in chronic HBV: An unmet need of growing importance.
DOI:10.1097/HEP.0000000000000722 PMID: 38088906 -
Pop A, Halegoua-DeMarzio D, Barnhart H, Kleiner D, Avigan M, Gu J, Chalasani N, Ahmad J, Fontana RJ, Lee W, Barritt AS, Durazo F, Hayashi PH, Navarro VJ. Dig Dis Sci, 2024 Apr; 69 (4): 1479 - 1487.Journal ArticleAmiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations.
DOI:10.1007/s10620-023-08251-2 PMID: 38416280 -
Mazumder NR, Fontana RJ. Annu Rev Med, 2024 Jan 29; 75: 233 - 245.Journal ArticleMELD 3.0 in Advanced Chronic Liver Disease.
DOI:10.1146/annurev-med-051322-122539 PMID: 37751367 -
Bonkovsky HL, Ghabril M, Nicoletti P, Dellinger A, Fontana RJ, Barnhart H, Gu J, Daly AK, Aithal GP, Phillips EJ, Kleiner DE, US DILIN Investigators . Liver Int, 2024 Mar 7;Journal ArticleDrug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations.
DOI:10.1111/liv.15892 PMID: 38451034 -
Colapietro F, Maisonneuve P, Lytvyak E, Beuers U, Verdonk RC, van der Meer AJ, van Hoek B, Kuiken SD, Brouwer JT, Muratori P, Aghemo A, Carella F, van den Berg AP, Zachou K, Dalekos GN, Di Zeo-Sánchez DE, Robles M, Andrade RJ, Montano-Loza AJ, van den Brand FF, Slooter CD, Macedo G, Liberal R, de Boer YS, Lleo A, Dutch AIH Study Group , International Autoimmune Hepatitis Group . J Hepatol, 2024 Jan; 80 (1): 53 - 61.Journal ArticleIncidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
DOI:10.1016/j.jhep.2023.09.010 PMID: 37802188 -
Asif BA, Koh C, Phillips EJ, Gu J, Li Y-J, Barnhart H, Chalasani N, Fontana RJ, Hayashi PH, Navarro VJ, Hoofnagle JH, Drug Induced Liver Injury Network (DILIN) . J Allergy Clin Immunol Pract, 2024 Jan; 12 (1): 168 - 174.e2.Proceeding / Abstract / PosterVancomycin-Induced Liver Injury, DRESS, and HLA-A∗32:01.
DOI:10.1016/j.jaip.2023.09.011 PMID: 37739311 -
Evon DM, Lin H-HS, Khalili M, Wahed AS, Yim C, Fontana RJ, Hoofnagle JH, Hepatitis B Research Network (HBRN) . Dig Dis Sci, 2023 Dec; 68 (12): 4499 - 4510.Proceeding / Abstract / PosterSymptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial.
DOI:10.1007/s10620-023-08108-8 PMID: 37804353
Department News
Join us for the 27th Annual Liver Disease Wrap-Up conference taking place on Saturday, December 7, 2024
Health Lab
Glucagon-like peptide-1, or GLP-1, receptor agonists, that aid in weight loss, are now being investigated for their ability to help other patients, including those with liver disease. However, a research letter discusses the first known case of hepatitis and jaundice in a patient taking these drugs.
Health Lab
Millions of Americans consume supplements that contain potentially hepatoxic botanical ingredients, according to a study from University of Michigan researchers.
